• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY INTERNATIONAL LTD. 801037 FCS CERAMIC 54 OR 56X28; DURALOC OPTION IMPLANTS : HIP CERAMIC ACETABULAR LINERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY INTERNATIONAL LTD. 801037 FCS CERAMIC 54 OR 56X28; DURALOC OPTION IMPLANTS : HIP CERAMIC ACETABULAR LINERS Back to Search Results
Catalog Number 159963054
Device Problems Fracture (1260); Device Dislodged or Dislocated (2923); Noise, Audible (3273)
Patient Problems Tissue Damage (2104); Fibrosis (3167); Not Applicable (3189)
Event Date 01/01/2018
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Revision due to soft tissue injury, instability, implant fracture, noise, and dislocation.
 
Manufacturer Narrative
Product complaint #: (b)(4).Investigation summary: no device associated with this report was received for examination.A worldwide complaint database search found no other reported incident(s) against the provided product/lot combination(s) since release for distribution.Corrective action was not indicated.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Product complaint # (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.'product complaint #: (b)(4).Investigation summary: the devices were reviewed by bioengineering and a report was received stating it is unlikely that a potential product issue was present root cause undetermined.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot: product code 159963054, lot number 1160577 was manufactured on dec 2003.(b)(4) parts were manufactured per specification and all raw materials met specification.There were no ncs or deviations associated with this lot.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FCS CERAMIC 54 OR 56X28
Type of Device
DURALOC OPTION IMPLANTS : HIP CERAMIC ACETABULAR LINERS
Manufacturer (Section D)
DEPUY INTERNATIONAL LTD. 801037
st. anthony's rd
leeds IN LS11 8 DT
UK  LS11 8 DT
MDR Report Key7905987
MDR Text Key121600708
Report Number1818910-2018-70382
Device Sequence Number1
Product Code MRA
Combination Product (y/n)N
PMA/PMN Number
P040023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup,Followup
Report Date 09/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/03/2008
Device Catalogue Number159963054
Device Lot Number1160577
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/28/2019
Initial Date Manufacturer Received 09/03/2018
Initial Date FDA Received09/25/2018
Supplement Dates Manufacturer Received10/02/2018
03/26/2019
05/29/2019
Supplement Dates FDA Received10/24/2018
04/15/2019
06/04/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age68 YR
-
-